Expression microarray analysis reveals alternative splicing of LAMA3 and DST genes in head and neck squamous cell carcinoma

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Li, Ryan ^a   Ochs, Michael F ^a,c   Ahn, Sun Mi ^a   Hennessey, Patrick ^a   Tan, Marietta ^a   Soudry, Ethan ^a   Gaykalova, Daria A ^a   Uemura, Mamoru ^a   Brait, Mariana ^a   Shao, Chunbo ^a   Westra, William ^a   Bishop, Justin ^a   Fertig, Elana J ^a   Califano, Joseph A ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b GREATER BALTIMORE MEDICAL CENTER   (United States)

^c The College of New Jersey   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALTERNATIVE RNA SPLICING; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DELTANP63 GENE; DST GENE; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; LAMA3 GENE; MALE; NUCLEOTIDE SEQUENCE; RASIP1 GENE; REAL TIME POLYMERASE CHAIN REACTION; SDHA GENE; TP63 GENE; VEGFC GENE; AGED; CANCER STAGING; DNA MICROARRAY; EXON; GENE EXPRESSION PROFILING; GENETICS; HEAD AND NECK TUMOR; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME; YOUNG ADULT;

CARRIER PROTEIN; CYTOSKELETON PROTEIN; DST PROTEIN, HUMAN; LAMININ; LAMININ ALPHA 3; NERVE PROTEIN; RNA ISOFORM; TP63 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ALTERNATIVE SPLICING; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CYTOSKELETAL PROTEINS; EXONS; FEMALE; GENE EXPRESSION PROFILING; HEAD AND NECK NEOPLASMS; HUMANS; LAMININ; MALE; MIDDLE AGED; NEOPLASM STAGING; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; RNA ISOFORMS; TRANSCRIPTION FACTORS; TUMOR BURDEN; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 84899798262     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091263     Document Type: Article

References (40)

1. Leemans CR, Braakhuis BJ, Brakenhoff RH (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11: 9-22.
2. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, et al. (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363: 24-35.
3. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, et al. (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100: 261-269. (Pubitemid 351480538)
4. Gillison ML, Zhang Q, Jordan R, Xiao W, Westra WH, et al. (2012) Tobacco smoking and increased risk of death and progression for patients with p16- positive and p16-negative oropharyngeal cancer. J Clin Oncol 30: 2102-2111.
5. Lassen P, Eriksen JG, Krogdahl A, Therkildsen MH, Ulhoi BP, et al. (2011) The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial. Radiother Oncol 100: 49-55.
6. Rischin D, Young RJ, Fisher R, Fox SB, Le QT, et al. (2010) Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol 28: 4142-4148.
7. Fortin A, Wang CS, Vigneault E (2009) Influence of smoking and alcohol drinking behaviors on treatment outcomes of patients with squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys 74: 1062-1069.
8. Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, et al. (2011) Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333: 1154-1157.
9. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, et al. (2011) The mutational landscape of head and neck squamous cell carcinoma. Science 333: 1157-1160.
10. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, et al. (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92: 709-720. (Pubitemid 30365531)
11. Venables JP, Klinck R, Koh C, Gervais-Bird J, Bramard A, et al. (2009) Cancer-associated regulation of alternative splicing. Nat Struct Mol Biol 16: 670-676.
12. Parsa R, Yang A, McKeon F, Green H (1999) Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. J Invest Dermatol 113: 1099-1105. (Pubitemid 30013359)
13. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, et al. (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2: 305-316. (Pubitemid 128379271)
14. Rocco JW, Leong CO, Kuperwasser N, DeYoung MP, Ellisen LW (2006) p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer Cell 9: 45-56. (Pubitemid 43069510)
15. Affymetrix GeneChip Exon Array Design, Technical Note.
16. Affymetrix Identifying and Validating Alternative Splicing Events, Technical Note.
17. Gardina PJ, Clark TA, Shimada B, Staples MK, Yang Q, et al. (2006) Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array. BMC Genomics 7: 325.
18. Xi L, Feber A, Gupta V, Wu M, Bergemann AD, et al. (2008) Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer. Nucleic Acids Res 36: 6535-6547.
19. Wang Z, Gerstein M, Snyder M (2009) RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10: 57-63.
20. Srinivasan K, Shiue L, Hayes JD, Centers R, Fitzwater S, et al. (2005) Detection and measurement of alternative splicing using splicing-sensitive microarrays. Methods 37: 345-359. (Pubitemid 41682505)
21. Chomczynski P (1993) A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15: 532-534, 536-537.
22. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159. (Pubitemid 17064313)
23. Carvalho BS, Irizarry RA (2010) A framework for oligonucleotide microarray preprocessing. Bioinformatics 26: 2363-2367.
24. Biosciences Q (2007-2009) qScript cDNA SuperMix Manual and Protocol.
25. Sniezek JC, Matheny KE, Westfall MD, Pietenpol JA (2004) Dominant negative p63 isoform expression in head and neck squamous cell carcinoma. Laryngoscope 114: 2063-2072. (Pubitemid 39602468)
26. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, et al. (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456: 470-476. (Pubitemid 352759009)
27. Klinck R, Bramard A, Inkel L, Dufresne-Martin G, Gervais-Bird J, et al. (2008) Multiple alternative splicing markers for ovarian cancer. Cancer Res 68: 657-663. (Pubitemid 351206740)
28. Venables JP, Klinck R, Bramard A, Inkel L, Dufresne-Martin G, et al. (2008) Identification of alternative splicing markers for breast cancer. Cancer Res 68: 9525-9531.
29. Chen AM, Chen LM, Vaughan A, Sreeraman R, Farwell DG, et al. (2011) Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome. Int J Radiat Oncol Biol Phys 79: 414-419.
30. Reis EM, Ojopi EP, Alberto FL, Rahal P, Tsukumo F, et al. (2005) Large-scale transcriptome analyses reveal new genetic marker candidates of head, neck, and thyroid cancer. Cancer Res 65: 1693-1699. (Pubitemid 40478594)
31. Wang K, Singh D, Zeng Z, Coleman SJ, Huang Y, et al. (2010) MapSplice: accurate mapping of RNA-seq reads for splice junction discovery. Nucleic Acids Res 38: e178.
32. Marinkovich MP (2007) Tumour microenvironment: laminin 332 in squamous-cell carcinoma. Nat Rev Cancer 7: 370-380.
33. Dajee M, Lazarov M, Zhang JY, Cai T, Green CL, et al. (2003) NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421: 639-643. (Pubitemid 36227672)
34. McGowan KA, Marinkovich MP (2000) Laminins and human disease. Microsc Res Tech 51: 262-279.
35. Cheng YS, Champliaud MF, Burgeson RE, Marinkovich MP, Yurchenco PD (1997) Self-assembly of laminin isoforms. J Biol Chem 272: 31525-31532. (Pubitemid 28013294)
36. Moller-Levet CS, Betts GN, Harris AL, Homer JJ, West CM, et al. (2009) Exon array analysis of head and neck cancers identifies a hypoxia related splice variant of LAMA3 associated with a poor prognosis. PLoS Comput Biol 5: e1000571.
37. Okumura M, Yamakawa H, Ohara O, Owaribe K (2002) Novel alternative splicings of BPAG1 (bullous pemphigoid antigen 1) including the domain structure closely related to MACF (microtubule actin cross-linking factor). J Biol Chem 277: 6682-6687. (Pubitemid 34968470)
38. Tamai K, Sawamura D, Do HC, Tamai Y, Li K, et al. (1993) The human 230-kD bullous pemphigoid antigen gene (BPAG1). Exon-intron organization and identification of regulatory tissue specific elements in the promoter region. J Clin Invest 92: 814-822. (Pubitemid 23262403)
39. Herold-Mende C, Kartenbeck J, Tomakidi P, Bosch FX (2001) Metastatic growth of squamous cell carcinomas is correlated with upregulation and redistribution of hemidesmosomal components. Cell Tissue Res 306: 399-408. (Pubitemid 33139898)
40. Hamill KJ, Hopkinson SB, DeBiase P, Jones JC (2009) BPAG1e maintains keratinocyte polarity through beta4 integrin-mediated modulation of Rac1 and cofilin activities. Mol Biol Cell 20: 2954-2962.